BAX vs. BTSG: Baxter vs. BrightSpring Health Services Stock Comparison

Company Profile

Baxter (BAX) and BrightSpring Health Services (BTSG) both fall under the Health Care Equipment & Services industry group, but BAX is classified in Health Care Equipment & Supplies while BTSG is classified in Health Care Providers & Services.

Baxter (BAX) carries decades of public-market history since October 27, 1981, while BrightSpring Health Services (BTSG) listed on January 26, 2024 — long-window comparisons have far more historical data on the BAX side.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

BrightSpring Health Services (BTSG) has an aggressive beta of 1.75, indicating higher sensitivity to broad-market moves, while Baxter (BAX) is defensive at 0.62 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Baxter (BAX) reports a negative ROE of -9.04%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile BrightSpring Health Services (BTSG) reports 15.54%, ranking against industry peers normally.

Baxter (BAX) reports a negative net margin of -6.23%, usually indicating a net loss over the period. Meanwhile BrightSpring Health Services (BTSG) reports 2.69%, ranking against industry peers normally.

Both Baxter (BAX) at 9.88% and BrightSpring Health Services (BTSG) at 3.81% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

BrightSpring Health Services (BTSG) at 28.18% sits in the top revenue growth quartile, while Baxter (BAX) at 5.72% is closer to the peer norm — faster top-line expansion for BTSG.

Neither Baxter (BAX) nor BrightSpring Health Services (BTSG) reports a EPS growth value for this period, so a direct comparison isn't possible.

Growth Metrics

Financial Strength

Both Baxter (BAX) at 1.79 and BrightSpring Health Services (BTSG) at 1.62 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

Both Baxter (BAX) at 1.36 and BrightSpring Health Services (BTSG) at 1.09 lean more heavily on debt funding than most peers, landing in the higher-leverage quartile of their industries.

Financial Strength Metrics

Dividends

BrightSpring Health Services (BTSG) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Baxter (BAX) reports a yield of 0.16%, ranking against industry peers normally.

Baxter (BAX) reports payout ratio above 100% at 154.67%, meaning dividends exceeded current-period earnings; BrightSpring Health Services (BTSG) pays no dividend (payout 0.00%).

Dividend Metrics

Valuation

An earnings multiple is available for just one side: BrightSpring Health Services (BTSG) trades at 47.62 times trailing earnings, ranked against its peers, while Baxter (BAX) has no P/E ratio this period.

BrightSpring Health Services (BTSG) at 0.88 sits in the cheaper P/S ratio quartile while Baxter (BAX) at 1.15 prices around its industry’s middle — BTSG costs less per dollar of sales, though read it alongside growth and margins.

Baxter (BAX) at 2.05 is valued about in line with its industry on P/B ratio, while BrightSpring Health Services (BTSG) at 6.39 carries an above-peer premium to book — BTSG is pricier on assets.

Valuation Metrics